Protection by Edaravone, a Radical Scavenger, against Manganese-Induced Neurotoxicity in Rats

Melda Apaydin1,2, Oytun Erbas3, Dilek Taskiran4

  • 1Department of Physiology, School of Medicine, Ege University, Izmir, Turkey.

Insights

Excessive manganese (Mn) exposure causes neurotoxicity and motor deficits in rats. Edaravone (EDA), a radical scavenger, effectively protected against these harmful effects, suggesting its therapeutic potential.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Manganese (Mn) is essential but toxic at high levels, causing manganism.
  • Neurotoxicity from excessive manganese exposure is a significant health concern.

Purpose of the Study:

  • To assess subacute manganese exposure effects on rat neurotoxicity.
  • To evaluate edaravone's protective role against manganese-induced neurotoxicity.
  • To measure manganese accumulation in the brain using MRI.

Main Methods:

  • Rats were exposed to manganese, with some treated with edaravone.
  • Evaluated weight gain, motor performance, and brain mitochondrial biochemical parameters (Complex I activity, lipid peroxides, protein carbonyls).
  • Magnetic resonance imaging (MRI) was used to quantify manganese brain accumulation.

Main Results:

  • Manganese exposure impaired motor performance, caused weight loss, and increased brain manganese levels.
  • Mitochondrial oxidative stress markers (lipid peroxides, protein carbonyls) increased, while Complex I activity decreased.
  • Edaravone treatment mitigated oxidative damage and improved motor function.

Conclusions:

  • Subacute manganese exposure induces significant neurotoxicity and mitochondrial dysfunction in rats.
  • Edaravone demonstrates protective effects against manganese-induced neurotoxicity.
  • Edaravone shows potential as a therapeutic agent for manganese neurotoxicity.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
158
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
167
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
185